TrialJournal of the American Heart Association2026

Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial.

What the trial testedrandomised · 400 people · 2026

Randomised comparison

27×14× to 50×

Bigger than almost all on the map

As reported

OR 26.58, 95% CI 14.1–50.0

the abstract, start to end

… <55 mg/dL: 63.2% versus 8.5%, OR, 26.58 [95% CI, 14.14-49.98]; …

← favours treatmentfavours comparator →

could be chance

Lipids

OR 26.5814.1–50.0

PCSK9 inhibitorsLipids

PCSK9 inhibitors × lipidshelps?settled

unlikelylikely

0.930.93 without it

← favours comparatorfavours treatment →

this papermore certainless certain

1 / 5